Patents Assigned to Viamet Pharmaceuticals, Inc.
  • METALLOENZYME INHIBITOR COMPOUNDS
    Publication number: 20110306644
    Abstract: The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
    Type: Application
    Filed: April 25, 2011
    Publication date: December 15, 2011
    Applicant: VIAMET PHARMACEUTICALS, INC.
    Inventors: William J. Hoekstra, Robert J. Schotzinger, Stephen W. Rafferty
  • METALLOENZYME INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES
    Publication number: 20110015158
    Abstract: The presently disclosed subject matter is described to metalloenzyme inhibitors having metal binding moieties linked to a targeting moiety through a linking group or a direct bond, method of screening for metalloenzyme inhibitors, and methods for treating a metalloenzyme related disorder by administering a metalloenzyme inhibitor to a subject in need of treatment thereof.
    Type: Application
    Filed: December 3, 2008
    Publication date: January 20, 2011
    Applicant: Viamet Pharmaceuticals, Inc.
    Inventors: Robert J. Schotzinger, William J. Hoekstra
  • METALLO-OXIDOREDUCTASE INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES
    Publication number: 20100305078
    Abstract: The presently disclosed subject matter is directed to metallo-oxidoreductase inhibitors having metal binding moities linked to a targeting moiety through a linking group or a direct bond, methods for screening for metallo-oxidoreductase inhibitors, and methods of treating an oxidoreductase related disorder by administering a metallo-oxidoreductase inhibitor to a subject in need of treatment thereof.
    Type: Application
    Filed: November 21, 2007
    Publication date: December 2, 2010
    Applicant: Viamet Pharmaceuticals, Inc.
    Inventors: Robert J. Schotzinger, William J. Hoekstra
  • Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties
    Publication number: 20100256082
    Abstract: The present invention is directed to methods for screening for metallohydrolase inhibitors using metal binding moieties in combination with targeting moieties.
    Type: Application
    Filed: June 12, 2007
    Publication date: October 7, 2010
    Applicant: Viamet Pharmaceuticals, Inc.
    Inventor: Robert J. Schotzinger
  • SCREENING FOR MODULATORS OF METALATION PATHWAYS FOR METALLOPROTEINS
    Publication number: 20090075836
    Abstract: The present invention is directed to compositions and methods for screening of metalation pathways for the metalation of metalloproteins.
    Type: Application
    Filed: October 20, 2006
    Publication date: March 19, 2009
    Applicants: Viamet Pharmaceuticals, Inc., Northwestern University, University of North Carolina at Chapel Hill
    Inventors: Herbert H. Thorp, Thomas V. O'Halloran
  • Compositions and Methods of Screening Apoproteins
    Publication number: 20080318248
    Abstract: The present invention is directed to compositions and methods of screening apoproteins for the elucidation of modulators of metalation of apoproteins.
    Type: Application
    Filed: October 20, 2006
    Publication date: December 25, 2008
    Applicant: Viamet Pharmaceuticals, Inc
    Inventors: Herbert Holden Thorp, JR., Thomas V. O'Halloran